Lucy Friedman, Ph.D.

grad student

1972

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Friedman LS, Simmons LH, Goldman RH, et al. (2014) Case records of the Massachusetts General Hospital. Case 12-2014. A 59-year-old man with fatigue, abdominal pain, anemia, and abnormal liver function. The New England Journal of Medicine. 370: 1542-50
Spoerke JM, O'Brien C, Huw L, et al. (2012) Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6771-83
Vijapurkar U, Robillard L, Zhou S, et al. (2012) mTOR kinase inhibitor potentiates apoptosis of PI3K and MEK inhibitors in diagnostically defined subpopulations. Cancer Letters. 326: 168-75
Wallin JJ, Edgar KA, Guan J, et al. (2011) GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway. Molecular Cancer Therapeutics. 10: 2426-36
Latané B, Friedman L, Thomas J. (1972) Affiliation in rats under stress Psychonomic Science. 27: 39-40